Copertina

Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yun Wang, Jiawei Wu, Yu Hong, Jiaying Zhu, Youcai Zhang, Jun Zhang, Chujie Ding, Yuan Che, Guangji Wang, Aiqin Jiang, Haiping Hao, Lijuan Cao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Targeting the tyrosine kinase Src in endothelium attenuates inflammation and atherogenesis induced by disturbed flow
di: Huanyu Ding, et al.
Pubblicazione: (2024)

Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator
di: Jiawei Zhang, et al.
Pubblicazione: (2024)

The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats
di: Srinivas Kamath, et al.
Pubblicazione: (2024)

Noncanonical function of sphingosine kinase 2 (SPHK2) sustains hepatic triglyceride homeostasis
di: Bingchuan Yuan, et al.
Pubblicazione: (2026)

The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin‐induced cardiomyopathy
di: Jing Wang, et al.
Pubblicazione: (2026)

Ginsenoside Rf protects against acetaminophen‐induced liver injury by targeting CCAR2 to activate the SIRT1‐FXR signalling pathway
di: Jingjing Fan, et al.
Pubblicazione: (2026)

Ginsenoside compound K up‐regulates β‐subunits of long‐chain L‐3‐hydroxyacyl‐CoA (HADHB) to promote fatty acid oxidation recovery and improve the balance of macrophage polarization in mice with ulcerative colitis
di: Lili Liu, et al.
Pubblicazione: (2026)

Circular RNA regulatory role in pathological cardiac remodelling
di: Alessia Bibi, et al.
Pubblicazione: (2024)

GL‐V9 inhibits Caspase‐11 activation‐induced pyroptosis by suppressing ALOX12‐mediated lipid peroxidation to alleviate sepsis
di: Li Chen, et al.
Pubblicazione: (2025)

Airway epithelial overexpressed cathepsin K induces airway remodelling through epithelial–mesenchymal trophic unit activation in asthma
di: Ling Qin, et al.
Pubblicazione: (2024)

Gut microbiota–derived trimethylamine‐N‐oxide protects pulmonary vascular barrier integrity via Vav guanine nucleotide exchange factor 3 (VAV3)‐mediated cytoskeletal remodelling in acute lung injury
di: Xilong Wang, et al.
Pubblicazione: (2026)

The sodium–glucose co‐transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor‐β
di: Ting‐ting Lyu, et al.
Pubblicazione: (2025)

The protein disulfide isomerase A3 and osteopontin axis promotes influenza‐induced lung remodelling
di: Amit Kumar, et al.
Pubblicazione: (2024)

The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases
di: Jiuguo Lin, et al.
Pubblicazione: (2024)

Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
di: Feng Zhang, et al.
Pubblicazione: (2024)

Pharmacological inhibition of the interleukin‐1 receptor‐associated kinase prevents angiotensin II‐induced cardiac remodelling in mice
di: Shreya Jaiswal, et al.
Pubblicazione: (2026)

Nuclear factor, erythroid 2 like 2 (NRF2)‐mediated disruption of iron homeostasis drives myocardial infarction progression
di: Deepthy Jayakumar, et al.
Pubblicazione: (2025)

Imperatorin ameliorates metabolic dysfunction‐associated fatty liver disease through modulating Suv39h1/Fabps/Cept1 signalling pathway
di: Yi Sun, et al.
Pubblicazione: (2025)

Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease
di: Guorong Tao, et al.
Pubblicazione: (2024)

Targeted peptide‐modified M2 exosomes drug delivery system for the targeted regulation of the lung injury microenvironment with isorhynchophylline (IRN): based on the inflammatory–metabolic–epigenetic synergy mechanism
di: Jin‐Ru Zou, et al.
Pubblicazione: (2026)

7 I, a structurally modified sinomenine, exerts dual anti‐GBM effects by inhibiting glioblastoma proliferation and inducing necroptosis which further mediates lysosomal cell death
di: Hong Yang, et al.
Pubblicazione: (2025)

Plumbagin, a novel TRPV2 inhibitor, ameliorates microglia activation and brain injury in a middle cerebral artery occlusion/reperfusion mouse model
di: Meihuizi Ding, et al.
Pubblicazione: (2024)

Covalent fluorescent probes for 2‐arachidonoylglycerol metabolic pathways
di: Nick D. F. Puijmbroeck, et al.
Pubblicazione: (2026)

Metformin aggravates pancreatitis by regulating the release of oxidised mitochondrial DNA via the frataxin (FXN)/ninjurin 1 (NINJ1) signalling pathway
di: Guang Xin, et al.
Pubblicazione: (2025)

SGLT2 inhibitors and their influence on iron metabolism in the context of inflammation
di: Helene G. Meyer, et al.
Pubblicazione: (2025)

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
di: Andrea Baragetti, et al.
Pubblicazione: (2026)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
di: Luca Botticelli, et al.
Pubblicazione: (2025)

Colchicine effect on biomarkers of cardiac remodelling and atherosclerosis in ST‐elevation myocardial infarction: A randomized controlled trial
di: Hanan Ahmed Hassanain, et al.
Pubblicazione: (2024)

Neutrophil extracellular traps drive tubulointerstitial fibrosis via the coiled‐coil domain‐containing protein 25 (CCDC25)–Yes‐associated protein 1 (YAP1) axis‐mediated autophagy regulation
di: Xinhui Hu, et al.
Pubblicazione: (2026)

α‐Linolenic acid suppresses Th17 cell differentiation to mitigate allergic rhinitis by binding to Lyn kinase in mast cells
di: Yuejin Wang, et al.
Pubblicazione: (2026)

Investigation of absorption, metabolism, and excretion of [ 14 C]pruxelutamide (GT0918), an androgen receptor antagonist in humans
di: Yuan‐dong Zheng, et al.
Pubblicazione: (2025)

Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes
di: Takatoshi Sakata, et al.
Pubblicazione: (2025)

A deep neural network model for optimizing traditional Chinese medicine prescriptions with data augmentation
di: Xiaohan Mao, et al.
Pubblicazione: (2025)

Immunomodulation by juglone alleviates acute graft‐versus‐host disease without compromising the graft‐versus‐leukaemia activity in mice
di: Dievya Gohil, et al.
Pubblicazione: (2024)

Klebsiella pneumoniae contributes to altered cytotoxicity of thiopurines in vitro: Possible implications of biotransformation and bacterial metabolism
di: Martina Franzin, et al.
Pubblicazione: (2025)

TRPC6 suppresses liver fibrosis by inhibiting hepatic stellate cell activation via CaMK4‐CREB pathway
di: Shan Jiang, et al.
Pubblicazione: (2025)

Factor XII and prekallikrein promote microvascular inflammation and psoriasis in mice
di: Yurong Zhang, et al.
Pubblicazione: (2024)

Reconsidering the microbial origins of primary sclerosing cholangitis and related autoimmune disorders: A case for the antro‐duodenal microbiome
di: Richard Kellermayer, et al.
Pubblicazione: (2025)

PPARγ is a potential therapeutic target for radiation enteritis via suppressing ferroptosis, mediated by the GAPDH/glycosylation axis
di: Xi Zeng, et al.
Pubblicazione: (2025)

Host genetic variants in the lactose metabolism pathway associated with bifidobacterium abundance have prognostic value for immunotherapy efficacy
di: Wen‐Hui Liu, et al.
Pubblicazione: (2026)